A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

计划入组 2,120 人 · 首次发布于 2025 年 10 月 3 日

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

计划入组 91 人 · 首次发布于 2016 年 10 月 25 日

Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients

计划入组 279 人 · 首次发布于 2012 年 7 月 2 日

Mixed Nucleoside

Rx

Mixed-activated Killer Immune Cells

mixed protamine zinc human insulin lispro

Saul Centers Inc

United States

United Microelectronics

Gan & Lee Pharmaceuticals Co.,Ltd

China

Menarini Group and NewAmsterdam Pharma Win European Commission Approval for Obicetrapib

Novel Hypercholesterolemia Drugs Market to Reach USD 42.8 Billion by 2036 as Oral PCSK9 Inhibition and Gene Editing Expand Treatment Options

Junshi Biosciences' Ongericimab Approved in China for Hypercholesterolemia and Mixed Dyslipidemia